Jen Barnes
Impact in
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Receptor Mechanisms and Signaling 3
- DNA Repair Mechanisms 2
- Cancer therapeutics and mechanisms 2
-
- Neuroscience and Neuropharmacology Research 4
- Neuropeptides and Animal Physiology 4
- Co-authors
- Guy A. Higgins (3 shared papers)Deborah Evans (2 shared papers)D. I. C. SCOPES (2 shared papers)H. Thomas Rupniak (3 shared papers)Richard B. Anderson (2 shared papers)Jane Clapham (1 shared paper)A.D. Michel (2 shared papers)J. W. CLITHEROW (1 shared paper)
- Journals
- British Journal of Pharmacology (3 papers)Neuroscience (2 papers)Cancer Research (2 papers)Neuroreport (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Jen Barnes
15 papers receiving 472 citations
Peers
Comparison fields: 5 of 73
- Cellular and Molecular Neuroscience 151
- Developmental Neuroscience 27
- Physiology 164
- Neurology 49
- Biological Psychiatry 10
Countries citing papers authored by Jen Barnes
This map shows the geographic impact of Jen Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen Barnes more than expected).
Fields of papers citing papers by Jen Barnes
This network shows the impact of papers produced by Jen Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen Barnes. The network helps show where Jen Barnes may publish in the future.
Co-authors
The 25 scholars most cited alongside Jen Barnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 98 | |
| 2 | 1996 | 88 | |
| 3 | 2003 | 72 | |
| 4 | 1992 | 66 | |
| 5 | 1997 | 52 | |
| 6 | Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function. | 1996 | 46 |
| 7 | 2013 | 18 | |
| 8 | 2017 | 14 | |
| 9 | 1992 | 11 | |
| 10 | 1994 | 11 | |
| 11 | 2012 | 10 | |
| 12 | 1993 | 8 | |
| 13 | 1987 | 5 | |
| 14 | 2000 | 2 | |
| 15 | 2017 | 1 |
About Jen Barnes
Jen Barnes is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Physiology, Oncology and Organic Chemistry, having authored 15 papers that have together received 502 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (4 papers), Neuropeptides and Animal Physiology (4 papers), Receptor Mechanisms and Signaling (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Alzheimer's disease research and treatments (2 papers), DNA Repair Mechanisms (2 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (151 citations), Developmental Neuroscience (27 citations), Physiology (164 citations), Neurology (49 citations) and Biological Psychiatry (10 citations). Jen Barnes has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Guy A. Higgins, Deborah Evans, D. I. C. SCOPES, H. Thomas Rupniak, Richard B. Anderson, Jane Clapham, A.D. Michel, J. W. CLITHEROW, Paul Beswick and Ann G. Hayes. Their work appears in journals such as British Journal of Pharmacology, Neuroscience, Cancer Research, Neuroreport and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.